Patents Examined by Catheryne Chen
  • Patent number: 11865121
    Abstract: Administration of certain chromium complexes in combination with a starch provide unexpected benefits regarding increasing amino acid absorption, protein synthesis, exercise tolerance, lean muscle mass, skeletal muscle hypertrophy, muscle power, muscle endurance, muscle strength, FSR, and decreasing delayed onset muscle soreness, muscle protein breakdown, and fat mass.
    Type: Grant
    Filed: February 8, 2017
    Date of Patent: January 9, 2024
    Assignee: Nutrition21, LLC
    Inventor: James R. Komorowski
  • Patent number: 11857553
    Abstract: Administration of certain chromium complexes in combination with a starch provide unexpected benefits regarding increasing amino acid absorption, protein synthesis, exercise tolerance, lean muscle mass, skeletal muscle hypertrophy, muscle power, muscle endurance, muscle strength, FSR, and decreasing delayed onset muscle soreness, muscle protein breakdown, and fat mass.
    Type: Grant
    Filed: March 27, 2019
    Date of Patent: January 2, 2024
    Assignee: Nutrition21, LLC
    Inventor: James R. Komorowski
  • Patent number: 11801210
    Abstract: The present invention relates to novel cosmetic and therapeutic uses of one or more compounds of the general formula (1) as described herein. Furthermore, the present invention relates to compositions (products or, respectively, formulations), in particular for topical administration, preferably cosmetic or pharmaceutical compositions, comprising or consisting of compound(s) of formula (1) and one or more cosmetically and/or pharmaceutically acceptable carriers. The present invention also relates to novel uses of such compositions according to the invention.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: October 31, 2023
    Assignee: SYMRISE AG
    Inventors: Dominik Stuhlmann, Ann-Christin Weseloh, Nicole Titze, Sabine Lange, Sebastian Bruncke, Benoît Join, Gabriele Vielhaber, Marielle Le Maire, Karima Benaissi
  • Patent number: 11801220
    Abstract: The present invention relates to the use of pomegranate oil and fractions thereof for preventing and treating neurodegenerative diseases. Particularly, the present invention relates to emulsions of the pomegranate oil or fractions thereof for the prevention and treatment of brain diseases, including Creutzfeldt-Jacob disease (CJD) and multiple sclerosis (MS).
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: October 31, 2023
    Assignees: Hadasit Medical Research Services and Development Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Ruth Gabizon, Haim Ovadia, Oded Abramsky, Shlomo Magdassi, Liraz Larush
  • Patent number: 11771638
    Abstract: A non-aqueous composition is disclosed that includes ascorbic acid, a silicone oil, at least 15% by weight of an essential oil, propylene glycol, and glycerin, wherein at least 50% of the initial amount of ascorbic acid in the non-aqueous composition remains stable when the composition is stored for at least 1 month at room temperature.
    Type: Grant
    Filed: January 7, 2021
    Date of Patent: October 3, 2023
    Assignee: MARY KAY INC.
    Inventor: Isaac Thomas
  • Patent number: 11766397
    Abstract: The present invention provides bioactive compositions comprising Ficus serum fraction derived from Ficus cell juice of fresh Ficus leaves and a process of preparing the Ficus serum fraction. The compositions have biological activity capable of reducing skin hyperpigmentation.
    Type: Grant
    Filed: December 7, 2019
    Date of Patent: September 26, 2023
    Assignee: ISP INVESTMENTS LLC
    Inventor: Michael Koganov
  • Patent number: 11759493
    Abstract: A composition containing a synergistic association of lactitol, lactulose and Rhamnus frangula extract for the treatment of constipation is described.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: September 19, 2023
    Assignee: NEILOS S.R.L.
    Inventor: Umberto Di Maio
  • Patent number: 11744793
    Abstract: Disclosed is the use of cosmetic compositions comprising an oak extract, a grape seed extract and a green tea extract to protect the skin, scalp, hair and external mucosa against air pollutants.
    Type: Grant
    Filed: April 6, 2017
    Date of Patent: September 5, 2023
    Assignee: GIVAUDAN ITALIA S.P.A.
    Inventors: Giada Maramaldi, Martino Meneghin, Federico Franceschi, Stefano Togni, Salvatore Malandrino
  • Patent number: 11730749
    Abstract: Various embodiments of a gut microbiome modulating composition comprises a blend of a polyphenol and an oligosaccharide. Various embodiments of the polyphenol may comprise at least approximately 5% by weight chlorogenic acid. Various embodiments of the oligosaccharides may be standardized to a degree of polymerization of at least three to reduce digestibility. Administration of an effective amount of the gut microbiome modulating composition to a person or animal may stimulate the growth of at least one of Akkermansia muciniphila, Lactobacillus, and Bifidobacterium bacteria in the colon, which may reduce permeability of the colon, increases short chain fatty acid production in the colon, and/or modulate causes immunomodulation of human colon cells. The gut microbiome modulating composition may provide protective effects against obesity-related chronic diseases.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: August 22, 2023
    Assignee: Plexus Worldwide, LLC
    Inventors: Stephen Roman, Tianan Jiang, Marco Rebaza
  • Patent number: 11730683
    Abstract: A flavored wipe and method of manufacturing and dispensing the flavored wipe includes a solution of water and a flavoring component, especially those including a sweetener, such as stevia or other natural or artificial sweeteners. Flavored wipes may be dispensed from a system that includes a compartment to hold material configured for use as a wipe and that includes a solution with at least a flavoring component, with such dispenser having an opening in a compartment to dispense such wipes.
    Type: Grant
    Filed: March 2, 2015
    Date of Patent: August 22, 2023
    Inventors: Danielle R. Stangler, Julia M. Rossi, Ryan Stangler
  • Patent number: 11707497
    Abstract: The present invention is directed to compositions comprising purified Bombyx mori cocoon silk peptide fiber, refined Buglossoides arvensis seed oil, and optionally Blueberry extract, and related methods for decreasing inflammation and providing neuroprotection. The compositions provide synergistic effects and may be used to treat relevant diseases and disorders.
    Type: Grant
    Filed: April 14, 2022
    Date of Patent: July 25, 2023
    Assignee: Brain Health Holding LLC
    Inventors: Gregory Cumberford, Troylyn Ball, Marcus Goddard
  • Patent number: 11660283
    Abstract: The invention relates to compositions comprising complexes of ?-cyclodextrin and cannabinoids and/or complexes of ?-cyclodextrin and terpenes, methods of making these ?-cyclodextrin and cannabinoid complex-containing compositions, and methods of using the ?-cyclodextrin and cannabinoid complex-containing compositions. The invention also relates to food products comprising the ?-cyclodextrin and cannabinoid complex-containing compositions of this invention.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: May 30, 2023
    Assignee: Joyn Botanicals Ltd.
    Inventor: Joseph D Artiss
  • Patent number: 11653654
    Abstract: A composition for repelling insects is disclosed. The composition may include an active component made of (i) a combination of clove oil, geranium oil, and peppermint oil, (ii) a fixative, and (iii) a solubilizer. The composition may include (i) from about 2.5 to about 15 wt. % of an active component made only of (a) from about 0.1 to about 5.0 wt. % of clove oil, (b) from about 0.5 to about 15.0 wt. % of geranium oil, and (c) from about 0.1 to about 15.0 wt. % of peppermint oil, (ii) from about 3 to about 15 wt. % of a fixative, and (iii) from about 15 to about 45 wt. % of a solubilizer.
    Type: Grant
    Filed: June 9, 2022
    Date of Patent: May 23, 2023
    Assignee: S. C. JOHNSON & SON, INC.
    Inventor: Chyree S. Batton
  • Patent number: 11642388
    Abstract: An antidepressant compound preparation and a preparation method for same were disclosed, The antidepressant includes the following raw materials of Hypericum perforatum L., Paeonia lactiflora Pall., Gardenia jasminoides Ellis, Albizia julibrissin Durazz. and Moutan cortex. The raw materials are weighed in proportion to obtain extracts respectively, and the extracts are mixed to prepare a compound preparation. The compound preparation prepared by the present invention has the advantages of simple preparation, safety, low toxic and side effects, no dependence, etc., and can effectively alleviate depression mood.
    Type: Grant
    Filed: November 26, 2020
    Date of Patent: May 9, 2023
    Assignees: CHENLAND NUTRITION ALS INC., QINGDAO CHENLAND PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO., LTD.
    Inventors: Shengcan Zou, Jiancheng Zong, Wenyu Li, Lei Zong, Zengliang Zhang, Shanglong Wang
  • Patent number: 11638688
    Abstract: A cosmetic composition includes: (i) one or more vegetable butters in an amount of from 5 to 35% by weight of the total composition; (ii) one or more vegetable oils in an amount of from 20 to 50% by weight of the total composition; and (iii) starch in an amount of from 40 to 85% by weight of the total composition. The cosmetic composition is free from preservatives as defined herein.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: May 2, 2023
    Assignee: COSMETIC WARRIORS LIMITED
    Inventors: Mark Constantine, Margaret Joan Constantine, Helen Elizabeth Ambrosen, Rowena Jacqueline Bird
  • Patent number: 11596664
    Abstract: The invention relates to aboveground plant parts of Sideritis ssp. or extracts produced therefrom for use to boost cognitive performance.
    Type: Grant
    Filed: March 12, 2015
    Date of Patent: March 7, 2023
    Assignee: Finzelberg GmbH & Co. KG
    Inventors: Björn Feistel, Bernd Walbroel
  • Patent number: 11596663
    Abstract: Managing and treating elevated OS biomarkers in mammals such as companion animals with at least one of the supplements alpha-lipoic acid, carnitine, co-enzyme Q-10, ginger, green tea, licorice, milk thistle, garlic, honey. resveratrol, soybeans, tomatoes, turmeric, vitamin D, vitamin E, or selenium. Other compounds are Zinc, Vitamin E, Vitamin C, Quercetin, L-glutamine and Robuvit. Diagnosing an oxidative stress (OS) in a mammal detects an OS biomarker, selectively isoprostane and other antioxidant biomarkers such as HODE, microRNAs, TAC, GSH, MDA, and TNF-alpha. The sample can be saliva.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: March 7, 2023
    Assignee: HEMOPET
    Inventor: Winifred Jean Dodds
  • Patent number: 11590195
    Abstract: An improved plant medicament composition, comprising an extract of Sorghum bicolor plant material for treating sickle cell disease is described. A method for the preparation of said composition having the property of inhibiting sickle cells is also provided.
    Type: Grant
    Filed: October 9, 2019
    Date of Patent: February 28, 2023
    Inventor: Robert Swift
  • Patent number: 11564962
    Abstract: The present invention relates to a pharmaceutical composition comprising a maple leaf extract or fraction thereof for preventing or treating a retinal disease, a method for preventing or treating a retinal disease using the pharmaceutical composition, and a food composition comprising a maple leaf extract or fraction thereof for ameliorating the symptoms of a retinal disease. The pharmaceutical composition according to the present invention, which is effective for the treatment of a retinal disease, can be used pharmaceutically as a composition for preventing or treating a retinal disease, and can also be used advantageously as a health functional food.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: January 31, 2023
    Assignee: KOREA INSTITUTE OF ORIENTAL MEDICINE
    Inventors: Jin Yeul Ma, Kwang Il Park, Yeoun-Hee Kim, Tae Woo Oh, Won Kyung Cho, Dong-Gun Kim, Eun Hee Park
  • Patent number: 11564964
    Abstract: Methods for treating coronavirus infection, such as an infection caused by SARS-Cov-2 or MERS-Cov, in a subject in need thereof include administering to the subject a therapeutically effective amount of a composition comprising cnicin. Compositions comprising cnicin include an extract of C. benedictus or purified cnicin.
    Type: Grant
    Filed: February 19, 2021
    Date of Patent: January 31, 2023
    Assignee: King Abdulaziz University
    Inventors: Hani A. Alhadrami, Ahmed M. Sayed, Hossam M. Hassan, Usama R. Abdelmohsen, Mostafa E. Rateb